Expert Reviews - Expert Review of Anticancer Therapy - 8(4):553

Substantial progress has been made in understanding the pathogenesis of malignant melanoma at the cellular level, leading to the development of several new agents in the treatment of melanoma. The focus of this review is to summarize the emerging therapies and investigational agents in the treatment of melanoma over the last 5 years.

Full Text

PDF (1819 KB)

PDF Plus (1582 KB)

Users who read this article also read:

Cutaneous head and neck melanoma: the old and the new

Nestor R Rigual, Saurin R Popat, Vijay Jayaprakash, Wainwright Jaggernauth, Michael Wong

Expert Review of Anticancer Therapy, Mar 2008, Vol. 8, No. 3, Pages 403-412.

Chemoprevention of breast cancer

Aurelio B Castrellon, Stefan Glück

Expert Review of Anticancer Therapy, Mar 2008, Vol. 8, No. 3, Pages 443-452.

The REDUCE trial: chemoprevention in prostate cancer using a dual 5α-reductase inhibitor, dutasteride

Mireia Musquera, Neil E Fleshner, Antonio Finelli, Alexandre R Zlotta

Expert Review of Anticancer Therapy, Jul 2008, Vol. 8, No. 7, Pages 1073-1079.

RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer

Maya B Lodish, Constantine A Stratakis

Expert Review of Anticancer Therapy, Apr 2008, Vol. 8, No. 4, Pages 625-632.

Home

Journal home

TOC

Summary

Prev. Article | Next Article
View/Print PDF (1819 KB)
View PDF Plus (1582 KB)
Add to favorites
Email to a friend

TOC Alert | Citation Alert What is RSS?

Quick Links

•	Alert me when: New articles cite this article
•	Download to citation manager
•	Related articles found in: Expert Reviews
•	View Most Downloaded Articles

Quick Search